Dr. ZinX is an anti-viral supplement. On 2 April 2020, Advance Nanotek,[1] an Australian producer of zinc oxide, filed a joint patent application with AstiVita Limited,[2] for an antiviral composition that included various oral care products[3] containing hinokitiol as a vital component. The brand that is now incorporating this new invention is called Dr. ZinX and is likely to release its Zinc + Hinokitiol combination products in 2020.[4][5] On 18 May 2020, Dr. ZinX published test results for a “Quantitative suspension test for the evaluation of hinokitol's virucidal properties in the medical area” [6][7] Zinc is considered to be an essential dietary supplement and trace element in the body. Globally it is estimated that 17.3% of the population has inadequate Zinc intake.[8][9]
References
- ↑ https://www.advancenanotek.com/
- ↑ https://www.astivita.com.au/
- ↑ http://pericles.ipaustralia.gov.au/ols/auspat/applicationDetails.do?applicationNo=2020900820
- ↑ https://www.asx.com.au/asxpdf/20200520/pdf/44hzh0v8bqgvlx.pdf
- ↑ https://www.drzinx.com/
- ↑ https://www.asx.com.au/asxpdf/20200520/pdf/44hzh0v8bqgvlx.pdf
- ↑ https://www.drzinx.com/testresults] declaring a ‘3.25 log’ reduction (99.9% reduction) for a neat concentration in 5 minutes against COVID-19 surrogate Feline Coronavirus.[https://www.tga.gov.au/surrogate-viruses-use-disinfectant-efficacy-tests-justify-claims-against-covid-19
- ↑ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510072/
- ↑ https://academic.oup.com/jn/article/132/11/3422/4687273